Table 5.
Variables associated with moderate to severe steatosis in the rheumatoid arthritis sample.
| MI model n = 223 |
|||
|---|---|---|---|
| Odds ratio | 95% CI | p value | |
| Age, every 10 years | 1.12 | 0.82–1.54 | 0.46 |
| Male gender | 2.41 | 1.14–5.07 | 0.020 |
| BMI | 1.18 | 1.06–1.31 | 0.001 |
| Waist, cm | 0.99 | 0.96–1.03 | 0.81 |
| Cholesterol, mg/dl | 1.00 | 0.99–1.01 | 0.63 |
| Triglycerides, every 10 mg/dl | 1.09 | 1.00–1.18 | 0.029 |
| Glycaemia, mg/dl | 0.99 | 0.96–1.013 | 0.41 |
| Smoke | 1.41 | 0.65–3.06 | 0.38 |
| Hypertension | 1.76 | 0.86–3.59 | 0.12 |
| CRP, mg/dl | 0.95 | 0.66–1.37 | 0.81 |
| CDAI | 0.98 | 0.94–1.01 | 0.33 |
| Disease duration, months | 0.99 | 0.99–1.00 | 0.49 |
| Cumulative dosage MTX, g | 1.11 | 1.01–1.23 | 0.026 |
| Cumulative dosage steroids, g | 1.00 | 0.99–1.00 | 0.34 |
| Use of b/tsDMARDs | 1.26 | 0.58–2.72 | 0.55 |
b/tsDMARDS, biological or targeted-synthetic disease-modifying anti-rheumatic drugs; BMI, body mass index; CDAI, clinical disease activity index; CI, confidence interval; CRP, C-reactive protein; MI, multiple imputation; MTX, methotrexate.
Multiple regression analysis (ENTER method). Odds ratio is based on the risk of the dependent variable (moderate to severe liver steatosis), given the presence of the independent variable.